Immunotherapy

Immunotherapy-bannerOur aim is to undertake cutting edge research in fundamental immunology and develop this through clinical trials for patient benefit.

wraith-davidTheme Lead
Professor David Cameron Wraith

Director of the Institute of Immunology and Immunotherapy

View profile

About our research

The NIHR Birmingham Biomedical Research Centre brings together experts from University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham (as part of Birmingham Health Partners) to develop new treatments for patients with inflammatory joint, muscle, bowel and liver diseases. Immune mediated inflammatory diseases, such as arthritis, colitis and liver disease, are increasingly common and constitute a major cause of suffering and premature death.

Aims of our research

Our aim is to undertake cutting edge research in fundamental immunology and develop this through clinical trials for patient benefit. Practical application of the advances in fundamental immunology arising from the Institute is realised through our work in vaccine development and immunotherapy. The development of novel immunotherapies focuses on three important areas of clinical medicine, namely inflammation, cancer and autoimmune diseases.